Advantages of HeberFERON® in the treatment of patients diagnosed with basal cell carcinoma

Abstract

Introduction: HeberFERON® is the only Cuban drug of its kind in the world for the treatment of basal cell carcinoma; it combines the action of two interferons to inhibit tumor growth and eliminate or reduce lesions, even those complex, multiple and in advanced stages.

Objective: to establish the advantages of HeberFERON® in the treatment of patients with a diagnosis of basal cell carcinoma.

Method:a bibliographic review was carried out in the Scopus, BASE, Clinical-Key, SciELO and LILACS databases. The combination of terms was applied as a search strategy, using modality and disease. Of the 26 articles retrieved, 19 were selected for the development of the research.

Development: HeberFERON® is a therapeutic option that reduces the size of the tumor or the complete elimination of it and this is one of the most encouraging results by reducing the need to mutilate sections of skin or deformities in places as complicated as the face, especially when It is found near vital orifices such as the eye, nose, mouth, and ears.

Conclusions: it was concluded that HeberFERON® is a dual-function therapeutic option, heals the patient from the tumor and maintains his facial aesthetics, which avoids mutilations and deformities of the face; evidencing, in the cases in which it is applied, a favorable impact on the quality of life of the patients